Deep learning supercomputer turns its attention to drug discovery
Developing new drugs to help cure diseases is a challenge some of the world’s sharpest minds are focused on. It’s also something that’s enormously expensive and time-consuming — with new drugs sometimes taking years, and costing hundreds of millions of dollars, to bring to market.That’s where a United Kingdom-based company called BenevolentAI wants to help — and it’s using the world’s most advanced deep learning supercomputer to do so. The first company in Europe to use Nvidia’s state-of-the-art DGX-1 computer, the idea is to utilize cutting-edge chemical modeling algorithms to come up with ways to treat serious diseases faster than was previously thought possible. “We’re taking giant corpuses of data, hundreds of millions of documents and structured data sources, and using it to discover relationships between chemicals, diseases and information about the…
Link to Full Article: Deep learning supercomputer turns its attention to drug discovery
Sharing
